Biosearch, from Spain

Listed in:

Business: Chemistry, Pharmaceutical, Foods,

Auditor: BDO.

Last Balances States (Mn of EUR)

Date H1-2014 H1-2013 Var (%)
Total Assets 39.243 41.883 -6.3
Total Liabilities
16.200
18.430 -12.1
Equity
23.043
23.453 -1.75
Working Capital
4.991
0.215 2221.4
March 10, 2016

Basic Stock Information

Last Quote (EUR)
0.515
PER
-405.51
Capitalization (Mns of EUR)
29.715
Capitalization/Equity
1.2895
Last month variation (%)
25.610
Last 3 months variation (%)
22.619
Last 6 months variation (%)
17.045
Last 12 months variation (%)
-14.167

Last Financial Statement (Mn of EUR)

Date H1-2014 H1-2013 Var (%)
Revenue
8.352
8.930 -6.47
EBIT
0.159
0.428 -62.85
Net Profit
-0.241
0.034 -808.82
ROCE (%) 0.468 1.389 -66.31
ROE -0.010 0.001 -1100.0
ROA -0.006 0.001 -700.0
Net Profit over revenue -0.029 0.004 -825.0
EBIT over revenue 0.019 0.048 -60.42
EBITDA over revenue 0.163 0.198 -17.68
Assets Rotation 0.213 0.213 0.0
Earning per share (EUR) -0.00418 0.00059 -808.47

Stock-Market Evolution

Key Figures (EUR)

Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
H1 8.352 1.361 0.159 -0.241 -0.241 -0.029 0.019 -0.010 -0.006 4.991 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 17.246 3.181 0.578 -0.179 -0.073 -0.004 0.034 -0.003 -0.002 4.483 Details
H2 8.316 1.410 0.150 -0.213 -0.107 -0.013 0.018 -0.005 -0.003 4.483 Details
H1 8.930 1.771 0.428 0.034 0.034 0.004 0.048 0.001 0.001 0.215 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 16.294 2.075 -0.658 -1.291 -0.922 -0.057 -0.040 -0.039 -0.021 -2.153 Details
H2 7.367 0.831 -0.532 -0.912 -0.543 -0.074 -0.072 -0.023 -0.012 -2.153 Details
H1 8.927 1.244 -0.126 -0.379 -0.379 -0.042 -0.014 -0.016 -0.008 -1.401 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 15.289 2.021 -4.765 -5.083 -4.100 -0.268 -0.312 -0.164 -0.089 -4.441 Details
H2 7.798 1.067 -4.434 -4.590 -3.588 -0.460 -0.569 -0.143 -0.078 -4.441 Details
H1 7.491 0.954 -0.331 -0.493 -0.512 -0.068 -0.044 -0.018 -0.010 -5.332 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 16.989 3.459 0.971 1.050 0.637 0.037 0.057 0.021 0.013 -1.964 Details
H2 6.319 1.707 0.323 0.511 0.316 0.050 0.051 0.011 0.006 -1.964 Details
H1 10.670 1.752 0.648 0.539 0.321 0.030 0.061 0.010 0.006 -5.467 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 18.811 1.907 -12.235 -13.019 -9.413 -0.500 -0.650 -0.341 -0.170 5.849 Details
H2 9.456 1.012 -12.062 -12.531 -9.077 -0.960 -1.276 -0.329 -0.164 5.849 Details
H1 9.355 0.895 -0.173 -0.488 -0.336 -0.036 -0.018 -0.009 -0.005 5.643 Details

Additional information

  • Capitalization: Total number of shares x (1 - Treasury shares) x Last Quote = (57699522) x (1 - 0.000 ) x (0.515 EUR) = 29.715 Mns of EUR
  • PER: Last Quote (0.515 EUR) / Last annual earning per share (-0.00127) = -405.512

News